Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy
Abstract Anaphylaxis after mosquito bite is rare, but life threatening. No approved preventive therapy is available to date, but omalizumab could be a promising therapeutic option for reducing risk and improving quality of life in these patients.
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2021-10-01
|
| coleção: | Clinical Case Reports |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/ccr3.4935 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|